CHU NICE
Nice, Alpes Maritimes, 06000, France
Location contact
:Sophie-Myriam D Dridi
CONTACT
Carole Charavet
CONTACT
NCT Number: NCT06981871
The determination of the periodontal phenotype is an essential part of the periodontal diagnostic process, which must guide not only treatment but also prognosis (Kim et al. 2020).
This determination is based on the clinical assessment of 3 individual variables: gingival height/thickness and alveolar bone cortical thickness. Although these anatomical characteristics are genetically determined, they are also influenced by numerous acquired, endogenous or exogenous factors that can act at a general and/or local level. The periodontal phenotype is therefore specific to an individual and its 3 components vary over time according to the dental sectors and sites of each individual. For example, the morphology of this phenotype varies according to whether the gingiva is thick or thin, high or reduced, and the bone cortex is thick or thin, with all possible combinations. Clinicians need to know the distribution of these different types of phenotypes, particularly in the aesthetic areas they are concerned with, in order to better identify the most fragile ones in the face of the multiple daily stresses to which the periodontium may be subjected: muscular force, dental plaque, oral hygiene manoeuvres, parafunctionality, dental procedures....
However, studies on the prevalence of the periodontal phenotype are limited and mainly concern Asian, Indian and American populations, with very few studies on European populations. Main objective: To assess the prevalence of periodontal phenotypes in the upper and lower incisors of French subjects, according to tooth type and at the individual level. Secondary objective: Identification of potential risk indicators in relation to the type of periodontal phenotype."
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Nice, Alpes Maritimes, 06000, France
:Sophie-Myriam D Dridi
CONTACT
Carole Charavet
CONTACT
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of gingival thickness (Kan et al 2015) and keratinised tissue height of the incisors with UNC-15 peridontal probe (Hu-Freidy, USA) and clinical photography.
Time frame: At the inclusion
Assessment of gingival thickness
Time frame: At the inclusion
Evaluation of keratinised tissue height of the lower and upper incisors with UNC-15 peridontal probe (mm) and clinical photography.
Time frame: At the inclusion
Description of the gingiva
Time frame: At the inclusion
Global description clinical multiples evaluations ( Age, gender, smoking habit, orthodontic background, oral hygiene habit, oral ventilation, dysfunction, facial typology, chin shape, visibility of vascularisation and root convexity through the gum, gingival récession (Cairo), freinal insertion and skin type).
Time frame: At the inclusion
Global description clinical evaluation based on photographs.
Contact information is provided by the study sponsor or research team.
:Carole Charavet
CONTACT
:Sophie-Myriam D Dridi
CONTACT
Centre Hospitalier Universitaire de Nice
Other
Prevalence of Lower and Upper Incisor Periodontal Phenotypes and Risk Indicators in French Dental Students: a Bicentric Cross-sectional Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07294287
Dental Implants, Gingiva
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT06075641
Gingiva, Hypopigmentation
View Trial DetailsNCT03465670
Gingiva, Stomatognathic Diseases
Ferrara, Italy
View Trial DetailsNCT07085533
Achromatopsia, Color Vision Defects
Wuhan, China
View Trial Details